Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1974 1
1975 1
1980 1
1981 2
1982 2
1984 3
1985 3
1986 2
1989 2
1995 1
1996 1
1997 2
1999 1
2011 1
2012 2
2014 1
2020 1
2021 3
2022 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.
Ader F, Bouscambert-Duchamp M, Hites M, Peiffer-Smadja N, Poissy J, Belhadi D, Diallo A, Lê MP, Peytavin G, Staub T, Greil R, Guedj J, Paiva JA, Costagliola D, Yazdanpanah Y, Burdet C, Mentré F; DisCoVeRy Study Group. Ader F, et al. Lancet Infect Dis. 2022 Feb;22(2):209-221. doi: 10.1016/S1473-3099(21)00485-0. Epub 2021 Sep 14. Lancet Infect Dis. 2022. PMID: 34534511 Free PMC article. Clinical Trial.
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.
Siempos II, Kalil AC, Belhadi D, Veiga VC, Cavalcanti AB, Branch-Elliman W, Papoutsi E, Gkirgkiris K, Xixi NA, Kotanidou A, Hermine O, Porcher R, Mariette X; CORIMUNO-19 Collaborative Group; DisCoVeRy Study Group; ACTT-2 Study Group; ACTT-3 Study Group. Siempos II, et al. EClinicalMedicine. 2024 Feb 9;69:102472. doi: 10.1016/j.eclinm.2024.102472. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38361992 Free PMC article.
Type I interferons directly down-regulate BCL-6 in primary and transformed germinal center B cells: differential regulation in B cell lines derived from endemic or sporadic Burkitt's lymphoma.
Salamon D, Adori M, He M, Bönelt P, Severinson E, Kis LL, Wu L, Ujvari D, Leveau B, Nagy N, Klein G, Klein E. Salamon D, et al. Among authors: leveau b. Cytokine. 2012 Mar;57(3):360-71. doi: 10.1016/j.cyto.2011.12.001. Epub 2011 Dec 26. Cytokine. 2012. PMID: 22204827
Online self-sampling kits for human immunodeficiency virus and other sexually transmitted infections: Feasibility, positivity rates, and factors associated with infections in France.
Rahib D, Bercot B, Delagreverie H, Gabassi A, Delaugerre C, Salord H, Icard V, Le Thi TT, Leveau B, Khiri H, Digne J, Didelot MN, Pisoni A, Tuaillon E, Lydié N, Vandentorren S. Rahib D, et al. Among authors: leveau b. Int J STD AIDS. 2022 Mar;33(4):355-362. doi: 10.1177/09564624211066447. Epub 2022 Feb 10. Int J STD AIDS. 2022. PMID: 35144493
Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial.
Hites M, Lapique EL, Massonnaud CR, Belhadi D, Jamard S, Goehringer F, Danion F, Reignier J, de Castro N, Garot D, Lacombe K, Tolsma V, Faure E, Malvy D, Staub T, Courjon J, Cazenave-Roblot F, Dyrhol Riise AM, Leturnier P, Martin-Blondel G, Roger C, Akinosoglou K, Moing VL, Piroth L, Sellier P, Lescure X, Trøseid M, Clevenbergh P, Dalgard O, Gallien S, Gousseff M, Loubet P, Vardon-Bounes F, Visée C, Belkhir L, Botelho-Nevers É, Cabié A, Kotanidou A, Lanternier F, Rouveix-Nordon E, Silva S, Thiery G, Poignard P, Carcelain G, Diallo A, Mercier N, Terzic V, Bouscambert-Duchamp M, Gaymard A, Trabaud MA, Destras G, Josset L, Billard N, Han TH, Guedj J, Couffin-Cadiergues S, Dechanet A, Delmas C, Esperou H, Fougerou-Leurent C, Mestre SL, Métois A, Noret M, Bally I, Dergan-Dylon S, Tubiana S, Kalif O, Bergaud N, Leveau B, Eustace J, Greil R, Hajdu E, Halanova M, Paiva JA, Piekarska A, Rodriguez Baño J, Tonby K, Trojánek M, Tsiodras S, Unal S, Burdet C, Costagliola D, Yazdanpanah Y, Peiffer-Smadja N, Mentré F, Ader F; DisCoVeRy study group. Hites M, et al. Among authors: leveau b. J Infect. 2024 Mar;88(3):106120. doi: 10.1016/j.jinf.2024.106120. Epub 2024 Feb 16. J Infect. 2024. PMID: 38367705 Free article. No abstract available.
Online self-sampling kits to screen multipartner MSM for HIV and other STIs: participant characteristics and factors associated with kit use in the first 3 months of the MemoDepistages programme, France, 2018.
Rahib D, Delagreverie H, Gabassi A, Le Thi TT, Vassel E, Vodosin P, Leveau B, Pisoni A, Tuaillon E, Digne J, Icard V, Delaugerre C, Lydié N; pour le groupe MémoDépistages. Rahib D, et al. Among authors: leveau b. Sex Transm Infect. 2021 Mar;97(2):134-140. doi: 10.1136/sextrans-2020-054790. Epub 2021 Jan 4. Sex Transm Infect. 2021. PMID: 33397802
Biomechanics. A summary of perspectives.
LeVeau BF. LeVeau BF. Phys Ther. 1984 Dec;64(12):1812. doi: 10.1093/ptj/64.12.1812. Phys Ther. 1984. PMID: 6505025 No abstract available.
Soluble factors produced by activated CD4+ T cells modulate EBV latency.
Nagy N, Adori M, Rasul A, Heuts F, Salamon D, Ujvári D, Madapura HS, Leveau B, Klein G, Klein E. Nagy N, et al. Among authors: leveau b. Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1512-7. doi: 10.1073/pnas.1120587109. Epub 2012 Jan 17. Proc Natl Acad Sci U S A. 2012. PMID: 22307606 Free PMC article.
35 results